Lapatinib Tablet is anti-cancer medicine that is also suitable to be used for the treatment of solid tumors. Considered a dual tyrosine kinase inhibitor, it is indicated for breast cancer in combination with therapy for HER2/neu. This tablet is known to work by interrupting epidermal growth factor receptors and HER2/neu. It gets metabolized in the liver by CYP3A4 with a protein binding ability of more than 99%. Lapatinib has the molecular formula C29H26ClFN4O4S with a molar mass of 581.058 g/mol. Lapatinib Tablet has an elimination half-life of about 24 hours with multiple doses with excretion mainly in feces.
Minimum Order Quantity 50 Box
Dose 250 mg
Packaging Size 42 Tablets
Packaging Type Box
Usage Commercial, Clinical, Hospital, Personal
We are a leading Exporter and Manufacturer of Lapatinib Tablet.
Lapatinib is used in the treatment of breast cancer
Lapatinib In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Lapatinib blocks this signal, and thus stops the production of these cancer cells.
Nausea, Headache, Back pain, Breathing difficulty, Rash, Joint pain, Pain in extremities, Insomnia, Vomiting, Abdominal pain, Loss of appetite, Dyspepsia, Hot flushes, Diarrhoea, Cough, Nose bleed, Constipation, Stomatitis
Lapatinib Tablets exporter, Lapatinib Tablets manufacturer